ホーム › 小細胞肺がん › オハイオ › Cleveland
Cleveland、OHにおける小細胞肺がんの臨床試験
Clevelandとその周辺地域（約30マイル以内）の拠点で、小細胞肺がんに関する13件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
被験者募集中第2相
- University Hospitals Cleveland Medical Center /ID# 277556, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- The Cleveland Clinic Taussig Cancer Center, Cleveland
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
被験者募集中第2/3相
- University Hospitals Cleveland Medical Center, Cleveland
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
被験者募集中第1/2相
- University Hospitals Cleveland Medical Center, Cleveland
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
被験者募集中第1/2相
- University Hospitals Cleveland Medical Center, Cleveland
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
被験者募集中第3相
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic - Fairview Hospital Molly Pavilion, Cleveland
- Cleveland Clinic, Cleveland
- 他1件
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
被験者募集中第3相
- University Hospitals Cleveland Medical Center, Cleveland
- The Cleveland Clinic Cancer Center at Fairview Hospital, Moll Pavilion, Cleveland
- Cleveland Clinic Foundation, Cleveland
- 他1件
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
被験者募集中第1/2相
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
被験者募集中第2相
- University Hospital - Cleveland Medical Center, Cleveland
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
被験者募集中第2相
- Cleveland Clinic, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Cleveland Clinic, Cleveland
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
被験者募集中第1相
- Case Comprehensive Cancer Center, Cleveland
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
被験者募集中第1相
- Zelgen Site 104, Cleveland
他の都市における小細胞肺がんの試験
- Houston, TX26件の研究
- Arlington, VA23件の研究
- Boston, MA21件の研究
- New York City, NY21件の研究
- Nashville, TN20件の研究
- Los Angeles, CA20件の研究
- Orlando, FL15件の研究
- Dallas, TX13件の研究
- St. Louis, MO13件の研究
- Detroit, MI12件の研究
- Chicago, IL12件の研究
- Washington, DC12件の研究
Clevelandにおける他の研究
- 非小細胞肺癌43件の研究
- がん（全種類）36件の研究
- 乳がん35件の研究
- 前立腺がん34件の研究
- 心不全33件の研究
- 転移性癌30件の研究
- 卵巣がん30件の研究
- 肺がん26件の研究
- 大腸癌24件の研究
- 心血管疾患22件の研究
- 子宮内膜がん20件の研究
- 急性骨髄性白血病20件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。